Boundless Bio BOLD
NASDAQ BOLD
$2.51 -0.05 (-1.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) Preferred Stock Liabilities (2023 - 2024)

Updated

Boundless Bio (BOLD) recorded Preferred Stock Liabilities of $247.62 million in Q1 2024, up 67.4% from $147.95 million a year earlier and unchanged from the prior quarter.

Analysis

Boundless Bio (BOLD) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Starting with Q1 2023, Boundless Bio's Preferred Stock Liabilities history includes 5 quarters.

  • Per Business Quant, the preceding three quarters came in at $247.62 million (Q4 2023), $247.62 million (Q3 2023) and $247.62 million (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Boundless Bio 56.41 Mn 56.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 247.62 Mn
Dec 31, 2023 247.62 Mn
Sep 30, 2023 247.62 Mn
Jun 30, 2023 247.62 Mn
Mar 31, 2023 147.95 Mn
API Access

Boundless Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BOLD&period=max&api_key=YOUR_API_KEY